<?xml version="1.0" encoding="utf-8"?>
<IndexPatientGuideline ID="x23284" Name="Guideline Statement 14" IsComponent="true" Changed="20260819T17:12:49" Created="20260818T18:39:28" Published="20260903T08:43:18" SiteBaseUrl="https://www.auanet.org" Locale="" XPowerPath="/Home/Guidelines &amp; Quality/Guidelines/Clinical Guidelines/Non-Muscle Invasive Bladder Cancer/TURBT/Repeat Resection: Timing, Technique, Goal, Indication/Guideline Statement 14">
  <IGX_Categories Count="0" CategoryIds="" />
  <LingualMaps />
  <Header type="string" UID="faf9fd2842b549d09e761cd943c2be20" label="Header" readonly="false" hidden="false" required="false" indexable="false" CIID="">Guideline Statement 14</Header>
  <BodyCopy type="xhtml" UID="41a2d8598c364193bbfe9ad86d7bcd3c" label="Body Copy" readonly="false" hidden="false" required="false" indexable="false" Height="" CIID="">&lt;p&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;In patients with high-grade Ta tumors, clinicians may perform repeat TUR of the primary tumor site within six weeks of the initial TURBT. (&lt;em&gt;Conditional Recommendation; Evidence Level: Grade C&lt;/em&gt;)&lt;/strong&gt;&lt;/p&gt;</BodyCopy>
  <DiscussionLinkName type="string" UID="b364402056154f78b38cd8d663eaf3ba" label="Discussion Link Name" readonly="false" hidden="false" required="false" indexable="false" CIID="">Discussion</DiscussionLinkName>
  <DiscussionTitle type="string" UID="ceedafe4ad314b5d8d3225bc0083b81c" label="Discussion Title" readonly="false" hidden="false" required="false" indexable="false" CIID="">Discussion</DiscussionTitle>
  <DiscussionBody type="xhtml" UID="9bbbac02721d4eefba59c63ee7ff9007" label="Discussion Body" readonly="false" hidden="false" required="false" indexable="false" Height="" CIID="">&lt;p&gt;Residual tumor can be found at the time of repeat resection in up to 50% of patients with high-grade Ta disease, with up to 15% of such tumors being upstaged.&lt;sup&gt;157-160&lt;/sup&gt; Larger and multifocal tumors are at a particularly increased risk for incomplete initial resection, and it is this incomplete resection that is likely a significant contributing factor to inadequately treated tumors that are then diagnosed as early recurrences.&lt;sup&gt;161&lt;/sup&gt; Nevertheless, the Panel acknowledges the paucity of data demonstrating an absolute therapeutic benefit to repeat resection for high-grade Ta tumors, and recognizes that in select cases, for example small high-grade Ta lesions in which a visually complete initial resection was performed, repeat resection may not be necessary. Thus, the Panel advocates careful consideration for repeat resection for these patients.&lt;/p&gt;</DiscussionBody>
</IndexPatientGuideline>